The classically recognized functions of the renin-angiotensin system are mediated by type 1 (AT 1 ) angiotensin receptors. Whereas man possesses a single AT 1 receptor, there are two AT 1 receptor isoforms in rodents (AT 1A and AT 1B ) that are products of separate genes (Agtr1a and Agtr1b). We have generated mice lacking AT 1B (Agtr1b ؊͞؊) and both AT 1A and AT 1B receptors (Agtr1a ؊͞؊Agtr1b ؊͞؊). Agtr1b ؊͞؊ mice are healthy, without an abnormal phenotype. In contrast, Agtr1a ؊͞؊Agtr1b ؊͞؊ mice have diminished growth, vascular thickening within the kidney, and atrophy of the inner renal medulla. This phenotype is virtually identical to that seen in angiotensinogen-deficient (Agt؊͞؊) and angiotensin-converting enzyme-deficient (Ace ؊͞؊) mice that are unable to synthesize angiotensin II. Agtr1a ؊͞؊Agtr1b ؊͞؊ mice have no systemic pressor response to infusions of angiotensin II, but they respond normally to another vasoconstrictor, epinephrine. Blood pressure is reduced substantially in the Agtr1a ؊͞؊ Agtr1b ؊͞؊ mice and following administration of an angiotensin converting enzyme inhibitor, their blood pressure increases paradoxically. We suggest that this is a result of interruption of AT 2 -receptor signaling. In summary, our studies suggest that both AT 1 receptors promote somatic growth and maintenance of normal kidney structure. The absence of either of the AT 1 receptor isoforms alone can be compensated in varying degrees by the other isoform. These studies reaffirm and extend the importance of AT 1 receptors to mediate physiological functions of the renin-angiotensin system.
The renin-angiotensin system (RAS) regulates blood pressure and body fluid balance and plays a role in growth and development (1) (2) (3) . The biological functions of the RAS and its major effector peptide, angiotensin II, are mediated by specific receptors. Two angiotensin receptor subtypes, type 1 angiotensin receptor (AT 1 ) and AT 2 , can be distinguished pharmacologically. The classically recognized actions of the RAS are mediated by AT 1 receptors (1, 2) . Whereas man possesses a single AT 1 receptor, rodents possess two AT 1 receptor isoforms, designated AT 1A and AT 1B . These receptors are the products of distinct but highly homologous genes (Agtr1a and Agtr1b) located on separate chromosomes (3, 4) . Expression of the AT 1A receptor subtype predominates in nearly all tissues except the anterior pituitary gland and the adrenal cortex, where AT 1B receptors are more highly expressed (5) (6) (7) (8) (9) . Because pharmacological AT 1 receptor antagonists block both AT 1A and AT 1B receptors, it has been difficult to separate their distinct functions (2) .
Experiments using gene targeting have provided insight into the roles of RAS genes in regulating blood pressure, body fluid homeostasis, and development. For example, mice that are unable to generate angiotensin II because of targeted mutations in the angiotensinogen (Agt Ϫ͞Ϫ) or angiotensinconverting enzyme (Ace Ϫ͞Ϫ) genes have virtually identical phenotypes characterized by reduced survival, low blood pressure, and abnormal kidney structure. In the kidney, these animals develop thickening of arterial walls, focal areas of renal cortical inflammation, and hypoplasia of the inner medulla, which is associated with a defect in urinary concentrating function (10) (11) (12) (13) . The reduced survival and kidney abnormalities of Agt Ϫ͞Ϫ mice can be rescued by human renin and angiotensinogen transgenes (14) .
Thus, the absence of angiotensin II results in a severe phenotype. Two major features of this phenotype, reduced survival and abnormal kidney morphology, are not recapitulated by targeted deletions of the individual angiotensin receptors, AT 1A , AT 1B , or AT 2 (15) (16) (17) (18) (19) (20) . Furthermore, the relative roles of each of these receptors in the regulation of blood pressure and circulatory homeostasis are not clear. To define the contribution of the AT 1 receptor subtypes to these phenotypes, we have generated mice lacking AT 1B receptors (Agtr1b Ϫ͞Ϫ) and mice lacking both AT 1A and AT 1B receptors (Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ). These animals have reduced growth, abnormal kidney structure, and reduced blood pressure. In the mice that completely lack AT 1 receptors, we find evidence for regulation of blood pressure by AT 2 receptors.
MATERIALS AND METHODS
Generation of AT 1B Receptor-Deficient Mice. To clone the Agtr1b gene, we used a probe that we had previously used to clone the AT 1A receptor (15) . This probe was used to screen a genomic library constructed with genomic DNA isolated from the mouse embryonic stem (ES) cell line E14tg2a that had been partially digested with the restriction endonuclease MboI. The phage clone containing the Agtr1b gene was identified by mapping using known sequences from the AT 1B receptor cDNA (3). Hybridizing phage was purified and a restriction map of the genomic DNA fragment was prepared, as depicted in Fig. 1A . To construct the targeting vector shown in Fig. 1B, a 10 .5-kb HindIII fragment containing all of the protein coding sequences was subcloned into pBluescript KS (Stratagene). A 0.4-kb MscI͞EagI fragment containing coding sequences was replaced by a neomycin resistance cassette (neo) from pMC1neopolA. The thymidine kinase (TK) gene from pMC1TK was inserted downstream of the 3Ј homology arm. ES cells were grown, transformed, and screened by using standard methodologies (21) . Colonies in which the plasmid had integrated by homologous recombination were identified by PCR using the primer pair depicted in Fig. 1C . The sequences for these primers are: TTGGGGACAAGGGTAT-CATAGCCA and TGGCGGACCGCTATCAGGAC.
Targeted ES cells were introduced into C57BL͞6 blastocysts. The resulting male chimeras were mated with C57BL͞6 or 129͞SvEv females to identify germ-line competent chimeras that were capable of transferring the ES cell genome to their offspring. The targeted Agtr1b allele was detected by Southern blot analysis of genomic DNA isolated from tail biopsies as shown in Fig. 1D . Offspring carrying the mutant allele were intercrossed to obtain animals that were homozygous for the targeted mutation (Agtr1b Ϫ͞Ϫ).
Production of Double Homozygous Agtr1a ؊͞؊Agtr1b ؊͞؊ Mice. Mice with targeted mutations of the AT 1A receptor gene (Agtr1a) have been produced in our laboratories as described previously (15) . Several breeding strategies were used to produce double homozygous Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice. First, Agtr1aϪ͞Ϫ and Agtr1b Ϫ͞Ϫ mice were crossed to produce double heterozygous Agtr1a ϩ͞ϪAgtr1b ϩ͞Ϫ animals that were then intercrossed. To increase the likelihood of obtaining double homozygotes, we also intercrossed Agtr1a
Ϫ͞ϪAgtr1b ϩ͞Ϫ or Agtr1a ϩ͞ϪAgtr1b Ϫ͞Ϫ mice. Finally, once double homozygous mice were obtained, they were crossed with Agtr1a Ϫ͞ϪAgtr1b ϩ͞Ϫ or Agtr1a ϩ͞ϪAgtr1b Ϫ͞Ϫ mice.
RNA Isolation and Reverse Transcription-PCR (RT-PCR) Analysis of AT 1B Expression. Adrenal glands were harvested from Agtr1b ϩ͞ϩ and Agtr1b Ϫ͞Ϫ mice and RNA was extracted from the tissues by using a commercially available reagent (Tri-reagent; Sigma). Total RNA was reverse transcribed to cDNA by using poly-dT (22) . A fragment of the AT 1B receptor cDNA was than amplified by PCR by using a sense primer derived from a portion from the Agtr1b gene that was deleted in the targeted gene (5Ј-ATACCGCTATG-GAATACCAG-3Ј) and an antisense primer from the 3Ј-region of the Agtr1b gene (5Ј-TTGATAACCCTGCATGC-GACC-3Ј). The diagnostic 700-bp fragment was identified on ethidium-stained gels. The presence and identity of the fragment were then confirmed by Southern blotting with a probe from the Agtr1b gene that was internal to the primer sequences.
Analysis of Growth and Development and Kidney Histology. To determine the effects of the combined Agtr1a͞Agtr1b gene disruptions on growth and development, we measured body weights along with wet weights of kidneys and heart in 4-month-old male wild-type and Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice. The major organs from these animals were fixed in formalin, sectioned, and stained with hematoxylin and eosin. The histomorphology of these organs was then examined by light microscopy.
Assessment of Urinary Concentrating Capacity. To examine the relative importance of the individual AT 1 receptors in urinary concentration, we measured urine osmolality in groups of wild-type (n ϭ 9), Agtr1a ϩ͞ϩAgtr1b Ϫ͞Ϫ (n ϭ 4), Agtr1a Ϫ͞ϪAgtr1b ϩ͞ϩ (n ϭ 14), and Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ (n ϭ 5) mice. Urine osmolalities were measured while mice had free access to drinking water and following 12 hours of complete water deprivation. Urine was collected after bladder massage and urine osmolality was measured immediately with a vapor pressure osmometer (Wescor, Logan, UT).
Vasoconstrictor Effects of Angiotensin II. In preparation for studies to assess the vascular effects of angiotensin II, the angiotensin converting enzyme (ACE) inhibitor enalapril was administered to groups of Agtr1a ϩ͞ϩAgtr1b ϩ͞ϩ (n ϭ 4), Agtr1a ϩ͞ϩAgtr1b Ϫ͞Ϫ (n ϭ 4) and Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ (n ϭ 4) mice to inhibit endogenous production of angiotensin II (23) . Thirty mg͞kg per day of enalapril was administered in the drinking water for 5 days. On the day of study, animals were anesthetized with isoflurane and a flexible plastic catheter (0.020ID; Braintree Scientific) was placed in the carotid artery to monitor arterial pressure. A second catheter was placed in the jugular vein to infuse angiotensin II. Intraarterial blood pressure was recorded continuously through the carotid catheter with a pressure transducer and WINDAQ acquisition and playback software (Dataq Instruments, Akron, OH).
Beginning with an equilibration period of 5 min, blood pressure was recorded continuously for the duration of the experiment at 50 recordings per sec. Data collected from each animal were compressed to five recordings per sec, and the mean arterial blood pressure (MAP) recordings from animals in each experimental group were integrated and averaged. Immediately after the equilibration period, mice received a bolus injection of 0.9% sodium chloride solution (NS) in a volume equal to 0.1% of their body weight. This is the volume used for each of the injections throughout the remainder of the experiment. At 10-min intervals thereafter, increasing doses of 0.1, 1.0, and 10 g͞kg of angiotensin II (Peninsula Laboratories) were injected intravenously. Ten minutes after the 10 g͞kg dose of angiotensin II, 10 g͞kg of epinephrine was administered intravenously and MAP was monitored for an additional 5 min. 
Systolic Blood Pressure Measurements in Conscious Mice.
Systolic blood pressures were measured in groups of Agtr1aϩ͞ϩAgtr1bϩ͞ϩ (n ϭ 8), Agtr1a ϩ͞ϩAgtr1b Ϫ͞Ϫ (n ϭ 10), and Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ (n ϭ 13) mice by using a computerized tail-cuff system (Visitech Systems, Cary, NC) as previously described (24) . Before the study was initiated, mice were adapted to the apparatus for at least 5 days. Systolic blood pressures were then measured for 10 days.
To examine the effect of reducing angiotensin II levels on blood pressure, these same groups of mice were treated with enalapril in drinking water at a dose of 30 mg͞kg per day for 10 days, during which their systolic blood pressures were measured.
Statistical Analysis. Data are presented as means Ϯ SEM. Statistical significance between groups was assessed by an unpaired t test or by analysis of variance (Bonferroni͞Dunn). Significance of comparisons within groups was determined by using a paired t test.
RESULTS AND DISCUSSION
Agtr1b Gene Targeting. The gene encoding the AT 1B receptor was disrupted in the E14Tg2a ES cell line by homologous recombination with the targeting plasmid shown in Fig. 1 . Targeted ES cell lines identified by PCR and confirmed by Southern blot analysis were introduced into blastocysts to generate chimeric mice. Male chimeras were crossed with female C57BL͞6 mice and Agtr1b ϩ͞Ϫ offspring carrying the mutant allele were identified by Southern blot analysis as shown in Fig. 1D .
Mice homozygous for the targeted mutation (Agtr1b Ϫ͞Ϫ) were generated by intercrossing Agtr1b ϩ͞Ϫ animals. Among the progeny of these crosses, 25% were Agtr1bϩ͞ϩ, 54% were Agtr1b ϩ͞Ϫ, and 21% were Agtr1b Ϫ͞Ϫ, corresponding to the proportions predicted by Mendelian inheritance. This shows that the absence of the AT 1B receptors does not significantly affect intrauterine development or perinatal survival. Furthermore, the Agtr1b Ϫ͞Ϫ animals could not be distinguished from wild-type littermates by simple observation. Histological examination of their major organ systems, including heart, kidney, and adrenal glands, did not reveal any pathological changes. Our findings confirm a previous report suggesting that the absence of AT 1B receptors is not associated with an abnormal phenotype (20) .
AT 1B Receptor mRNA Expression in Mutant Mice. To verify that the targeted mutation introduced into the Agtr1b locus resulted in inactivation of the gene, we examined expression of AT 1B receptor mRNA in adrenal glands by RT-PCR. As shown in Fig. 2 , AT 1B receptor mRNA could not be detected in Agtr1b Ϫ͞Ϫ mice, confirming the efficacy of the gene targeting strategy.
Production of Mice Lacking Both AT 1A and AT 1B Receptors. Because the Agtr1a and Agtr1b genes are located on different chromosomes (4), the mutations could be combined through simple breeding. Agtr1a Ϫ͞Ϫmice were crossed with Agtr1b Ϫ͞Ϫ mice to produce progeny that were heterozygous for both the Agtr1a and Agtr1b disruptions. These Agtr1a ϩ͞ϪAgtr1b ϩ͞Ϫ animals were then intercrossed to produce mice that were double homozygotes for the null Agtr1a and Agtr1b alleles. To increase the frequency of generating Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ animals, we also crossed mice that were heterozygous for one disruption and homozygous for the other (e.g., Agtr1a ϩ͞ϪAgtr1b Ϫ͞Ϫ ϫ Agtr1a Ϫ͞Ϫ Agtr1b ϩ͞Ϫ). Among 343 consecutive 21-day-old weanlings from these different crosses, there were significantly fewer Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ pups than predicted by simple Mendelian inheritance (29 observed vs. 50 expected; P ϭ 0.024 by 2 analysis). Thus, in these mixed breedings, the complete absence of AT 1 receptors is detrimental to survival, with an apparent perinatal mortality rate of approximately 40%. By comparison, the perinatal mortality rate of angiotensinogen-deficient (Agt Ϫ͞Ϫ) weanlings in our colony is approximately 60% (13 observed vs. 37 expected; P ϭ 0.0016 by 2 analysis). Once double homozygous Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice were obtained, some of these animals were crossed with Agtr1a Ϫ͞ϪAgtr1b ϩ͞Ϫ or Agtr1a ϩ͞ϪAgtr1b Ϫ͞Ϫ mice to further increase the frequency of producing Agtr1a Ϫ͞Ϫ Agtr1b Ϫ͞Ϫ animals. When the genotypes of pups from these litters were analyzed, the observed frequency of Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ weanlings was virtually identical to predicted (22 observed vs. 23 expected; P ϭ 0.9 by 2 . Thus, the survival disadvantage associated with the absence of AT 1 receptors can be overcome by selective breeding. This observation suggests that this trait can be modified significantly by background genes that are present in the C57BL͞6 ϫ 129 mixed breedings. In mice lacking only AT 1A receptors, we have identified similar modifying effects of background genes (25) .
Both male and female Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice are fertile. The frequency of productive matings, gestation, delivery, and care of litters was not different between Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ and wild-type females. Male Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice produced litters of normal size. Our group (12) and others (10) have previously identified fertility problems in male ACE-deficient mice, but not in male angiotensinogen-deficient mice (11) . In view of our current results, the defective fertility observed in ACEdeficient mice is not because of a lack of AT 1 -receptor signaling and may be caused by the loss of unique functions of testicular ACE probably unrelated to angiotensin II production. For example, other potential ACE substrates (bradykinin, enkephalins, and substance P) can alter functions of sperm (26, 27) .
Growth Is Impaired in Mice with Combined AT 1A ͞AT 1B Receptor Deficiency. In neonatal rats, AT 1 receptor antagonists impair somatic and renal growth (28) . However, in a previous study, we found that mice lacking only the AT 1A receptor grow and develop normally (29) . To determine whether the combined absence of AT 1A and AT 1B receptors adversely affects growth, we compared body, heart, and kidney weights between 4-month-old male wild-type and double homozygous Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice. The surviving Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice appeared healthy and could not be distinguished from wild-type littermates based on their external appearance. However, their body weights were significantly lower than wild-type mice (25.7 Ϯ 1.4 vs. 29.6 Ϯ 0.6g; P ϭ 0.05). In addition, both kidney weights (0.25 Ϯ 0.02 vs. 0.32 Ϯ 0.02 g; P ϭ 0.03) and heart weights (0.09 Ϯ 0. 01   FIG. 2 . Assessment of AT1B mRNA expression by RT-PCR. Total RNA was isolated from adrenal glands of two wild-type and two Agtr1b Ϫ͞Ϫ mice and each specimen was subjected to RT-PCR to amplify AT1B receptor mRNA. In tissues from the wild-type mice (lanes 1 and  2) , a PCR product of the expected size (700 bp) was detected on an ethidium bromide stained gel (A) and was confirmed to be AT1B receptor mRNA by hybridization (B). This band was not detected in RNA from the Agtr1b Ϫ͞Ϫ mice (lanes 3 and 4) .
vs. 0.13 Ϯ 0.01 g; P ϭ 0.02) were also significantly reduced in the AT 1 -deficient mice compared with wild-type controls. Because the ratios of heart weight to body weight (0.37 Ϯ 0.02% vs. 0.45 Ϯ 0.04%; P ϭ 0.1) and kidney weight to body weight (0.96 Ϯ 0.06% vs. 1.08 Ϯ 0.06%; P ϭ 0.2) are similar in Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ and wild-type control mice, the combined absence of AT 1A and AT 1B receptors appears to cause a generalized impairment of growth.
Abnormalities in Kidney Structure in Double Homozygous Agtr1a ؊͞؊Agtr1b ؊͞؊ Mice. Agt Ϫ͞Ϫ or Ace Ϫ͞Ϫ mice that are unable to synthesize angiotensin II develop structural abnormalities in the kidney. These include thickening of arterial walls, focal areas of interstitial fibrosis and tubular atrophy, and atrophy of the renal papilla (10, 11, 13) . The absence of any single known angiotensin II receptor, AT 1A , AT 1B , or AT 2 , does not completely recapitulate this phenotype (15) (16) (17) (18) (19) (20) . To determine whether the pathogenesis of these renal phenotypes requires the simultaneous absence of signaling through both AT 1A and AT 1B receptors, we examined renal histomorphology in Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice and compared them to wild-type controls. As depicted in Fig. 3B , Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice develop atrophy of the inner medulla that is easily detected by light microscopy. These mice also develop severe thickening of arterial walls within the kidney (Fig. 3D ) that resembles the vascular abnormalities seen in Agt Ϫ͞Ϫ and Ace Ϫ͞Ϫ mice (10-13). We also found focal areas of cortical interstitial inflammation, fibrosis, and tubular atrophy in the Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice (Fig. 3F) , similar to lesions that we observed in Agt Ϫ͞Ϫmice (11). These findings are in general agreement with those of Tsuchida et al., who recently reported that combined disruption of both AT 1 receptor genes produces a severe kidney phenotype (30) . There were no abnormalities noted in the histology of hearts and adrenal glands of Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice. In particular, there was no evidence of arterial or arteriolar thickening at these sites.
These data suggest that both AT 1 receptor isoforms contribute to the regulation of vascular structures in the kidney and to the maintenance of the renal papilla. Furthermore, as with the growth responses, the absence of a single AT 1 receptor isoform can be compensated by the other. However, the AT 1A receptors have a greater capacity for compensation than the AT 1B receptors, perhaps reflecting their relative levels of expression in kidney (15, 31) . Accordingly, renal morphology is completely normal in the Agtr1b Ϫ͞Ϫ mice that possess the full complement of AT 1A receptors. In contrast, subtle abnormalities can be detected in kidneys of AT 1A -deficient mice. By using magnetic resonance microscopy, modest reductions in the size of the renal papilla are revealed in Agtr1a Ϫ͞Ϫ mice that were not detected by routine pathological evaluation Proc. Natl. Acad. Sci. USA 95 (1998) 15499 [Oliverio et al., unpublished work] . In addition, minimal but significant thickening of renal interlobular arteries has been detected in Agtr1a Ϫ͞Ϫ mice by using a careful morphometric analysis (18) . Nonetheless, the difference between the modest abnormalities seen in Agtr1a Ϫ͞Ϫ mice and the florid pathology seen in double homozygous Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice must be due to compensation by the AT 1B receptor. This level of compensation seems remarkable because our previous studies have shown that AT 1B receptor binding is virtually undetectable in kidneys of Agtr1a Ϫ͞Ϫ mice (15) . Alternatively, it has been hypothesized that atrophy of the papilla may not depend directly on expression of AT 1 receptors in the kidney, but instead is related to loss of AT 1 receptor functions in the urinary collecting system (32) . AT 1 Receptors and Urinary Concentration. Among its many biological actions, the RAS regulates water metabolism, in part through diverse effects on urinary concentrating mechanisms (33, 34) . Whereas a range of abnormalities in water homeostasis has been described in mice lacking angiotensin II or AT 1A receptors, impairment of urinary concentrating capacity is a feature common to all of these mutants (10, (35) (36) (37) . To clarify the role of AT 1A and AT 1B receptors in these processes, we measured urinary concentrating capacities of wild-type, Agtr1a Ϫ͞Ϫ, Agtr1b Ϫ͞Ϫ, and Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice. As shown in Fig. 4 , after 12 hours of water deprivation, urine osmolalities in Agtr1b Ϫ͞Ϫ mice increased to the same extent as in wild-type controls. In contrast, Agtr1a Ϫ͞Ϫ mice have a defect in urinary concentration that is clearly apparent after 12 hours of water deprivation. Furthermore, the combined absence of both AT 1A and AT 1B receptors causes a urinary concentrating defect that is even more severe. Their urine osmolality remains virtually unchanged after 12 hours of water deprivation. Whereas this severe defect in the Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice is not unexpected given their inner medullary atrophy (see Fig. 3B ), the incremental differences in maximal urine osmolality between the three mutant groups further illustrate the relative abilities of the AT 1A and AT 1B receptor isoforms to compensate for one another.
Vasoconstrictor Actions of Angiotensin II. The vasoconstrictor actions of angiotensin II are mediated by AT 1 receptors (2). We have previously shown that the AT 1A receptor mediates a substantial portion of the pressor effects of angiotensin II based on the marked attenuation of these responses in Agtr1a Ϫ͞Ϫ mice (15) . However, when endogenous angiotensin II production is suppressed, a modest pressor and renal vasoconstrictor effect of angiotensin II can be detected in AT 1A -deficient mice. This response is blocked by AT 1 receptor antagonists, but not by sympatholytic agents, suggesting that it is a direct effect of AT 1B receptors (23, 38) .
To directly test this hypothesis and to clarify the role of other angiotensin receptors in the vasoconstrictor actions of angiotensin II, we examined pressor responses to angiotensin II in wild-type, Agtr1b Ϫ͞Ϫ and Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice. As shown in Fig. 5 , angiotensin II caused similar doseproportional increases in mean arterial pressure in the wild-type and Agtr1b Ϫ͞Ϫ mice. In contrast, angiotensin II had no discernable effect on MAP in the double homozygous Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice. To determine whether responses to other pressor agents might also be impaired in these animals, each group received an infusion of epinephrine after the angiotensin II infusions were completed. As shown in Fig. 5 , epinephrine caused vasoconstriction with significant and equivalent increases in MAP in all of the groups, including the Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice. These studies verify the importance of AT 1 receptors in the vasoconstrictor effects of angiotensin II. In addition, they confirm the conclusions from our previous study that the vasoconstrictor actions of angiotensin II in Agtr1a Ϫ͞Ϫ mice are mediated by AT 1B receptors (23) . Finally, the absence of any hemodynamic response to angiotensin II in Agtr1a Ϫ͞Ϫ Agtr1b Ϫ͞Ϫ mice suggests that there are no other angiotensin II receptors with significant vasoactive functions.
Systolic Blood Pressure Regulation in Mice Lacking AT 1A and AT 1B Receptors. Systolic blood pressures in Agtr1b Ϫ͞Ϫ and wild-type mice were similar (114 Ϯ 3 vs. 123 Ϯ 3 mmHg (1 mmHg ϭ 133 Pa). In contrast, blood pressure was significantly reduced in mice lacking both AT 1A and AT 1B receptors (87 Ϯ 3 mmHg; P Ͻ 0.0001 vs. wild-type or Agtr1b Ϫ͞Ϫ), as shown in Fig. 6 . This magnitude of blood pressure reduction is similar to levels that we have observed previously in Agtr1a Ϫ͞Ϫ (15) and Agt Ϫ͞Ϫ mice (11) .
To determine the contribution of endogenous angiotensin II to the maintenance of blood pressure in these animals, each group was subsequently treated with the ACE inhibitor enalapril for 2 weeks, during which time systolic blood pressure was monitored. As shown in Fig. 6 , the ACE inhibitor significantly lowered blood pressures in the wild-type animals. In contrast, ACE inhibition had a paradoxical effect on blood pressure in the mice lacking both AT 1A and AT 1B receptors. In these mice, administration of the ACE inhibitor caused a significant rise in blood pressure from 87 Ϯ 3 to 94 Ϯ 3 mmHg (P ϭ 0.03). Following ACE inhibition, systolic blood pressures in the Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice were not significantly different from the wild-type mice on enalapril. We speculate that the paradoxical effect of ACE inhibition to increase blood pressure in Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice represents inhibition of AT 2 receptor signaling. This would be consistent with studies suggesting that AT 2 receptors oppose the actions of AT 1 receptors on blood pressure (16, 17) and other cellular functions (39) . Because angiotensin II infusions do not alter blood pressure in Agtr1a Ϫ͞ϪAgtr1b Ϫ͞Ϫ mice (see Fig. 4 ), AT 2 receptors may regulate blood pressure by modulating renal sodium excretion rather than by affecting vascular tone.
